Anti-HtrA1 antibodies and methods of use thereof
US10421822B2 · kind B2 · utility
2Cited by
113References
52Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 23, 2018 |
| Grant date | Sep 24, 2019 |
| Priority date | — |
| Expiry date | Oct 23, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides anti-HtrA1 antibodies (including bispecific anti-HtrA1 anti-Factor D antibodies) and methods of making and using the same, for example, in methods of treating HtrA1-associated disorders, ocular disorders, and/or complement-associated disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.